AU2003271024A1 — Sustained release compound of acetamidophenol and tramadol
Assigned to Individual · Expires 2004-04-08 · 22y expired
What this patent protects
A sustained release formulation as a unit dose contains 100 mg - 1000 mg of Acetaminophen and 15 mg - 150 mg of tramadol hydrochloride, which comprises of 1) an immediate release portion comprising of 25% - 75% of the total effective amount of drug in the dosage form and 2) a sus…
USPTO Abstract
A sustained release formulation as a unit dose contains 100 mg - 1000 mg of Acetaminophen and 15 mg - 150 mg of tramadol hydrochloride, which comprises of 1) an immediate release portion comprising of 25% - 75% of the total effective amount of drug in the dosage form and 2) a sustained release portion comprising of a) 25% - 75% of the total effective amount of drugs in the dosage form; b) 6% - 50% of gelling polymers of the total formulation, and c) optionally an enteric coating at a level of 5% - 40% of the total formulation. The set forth formulation dissolves 25% - 60% of the total drug in the first hour, 50% - 90% of the total drug in the first four hours and not less than 80% of the total drug in the first 12 hours using USP dissolution method II at 50 rpm.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.